SÜSS MicroTec (SMHN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Achieved record Q3 2024 sales of €102.5m, up 46.4% YoY, with the highest EBIT margin of the year at 16.9% and best quarterly performance.
Order book reached €430.8m, up 3.9% YoY, ensuring high capacity utilization and visibility into 2025.
Sale of SUSS MicroOptics S.A. completed, resulting in €75m cash inflow and €58.3m gain, boosting net profit and cash.
Both Advanced Backend Solutions and Photomask Solutions segments contributed to strong sales and margin growth.
Financial highlights
9M 2024 sales rose 46.0% YoY to €295.3m; gross profit margin improved by 6.1pp to 39.6%; EBIT margin up 9.8pp to 16.1%.
Net profit reached €93.8m, including €58.3m from discontinued MicroOptics operations; EPS (basic, continuing) at €1.85, up 262.7% YoY.
Free cash flow from continuing operations at €24.2m; total free cash flow including discontinued operations at €95.0m.
Equity ratio improved to 55.2% as of September 30, 2024; cash and cash equivalents at €136.1m.
Net cash increased to €122.3m (+274.0% YoY).
Outlook and guidance
On track to achieve the upper half of raised 2024 guidance: sales €380–410m, gross profit margin 38–40%, EBIT margin 14–16%.
Strong order book and margin momentum support positive outlook into 2025.
Further production capacity expansion underway, including a new site in Zhubei, Taiwan, expected to double cleanroom space by H2 2025, with €15–20m capex planned.
Latest events from SÜSS MicroTec
- Sales up 45.6%, EBIT margin at 15.6%, and guidance raised on strong order momentum.SMHN
Q2 20242 Feb 2026 - Record sales and margins in 2024 set a strong outlook for 2025 despite one-off costs.SMHN
Q4 202423 Dec 2025 - Record sales and EBIT growth offset by lower order intake and margin pressure, prompting guidance cuts.SMHN
Q2 202523 Nov 2025 - Sales targeted at €750–900 million and 43–45% margin by 2030, led by innovation and services.SMHN
CMD 202521 Nov 2025 - Q1 2025 sales up 31.8%, profit surged, but order intake fell amid rising macro risks.SMHN
Q1 202521 Nov 2025 - Margin pressure and lower net income prompt guidance cut, but Q4 order rebound expected.SMHN
Q3 202513 Nov 2025 - 2025 margin guidance cut after Q3 profit drop; cost actions underway, Q4 orders seen rising.SMHN
Q3 2025 TU6 Nov 2025